Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | HSD17B1 | P14061 | 10/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 10/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | NQO2 | P16083 | 2/20 | 0.36 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | PRF1 | P14222 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12546443 | 0.98 | L3MBTL1 (0.55) | L3MBTL1KDM4EATMHSD17B1HSD17B2 | |
| SCHEMBL31357350 | 0.90 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMHSD17B1HSD17B2 | |
| SCHEMBL23044992 | 0.89 | L3MBTL1 (0.67) | L3MBTL1KDM4EATMHSD17B1HSD17B2 | |
| SCHEMBL14208768 | 0.89 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMHSD17B1HSD17B2 | |
| SCHEMBL12546406 | 0.87 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMHSD17B1HSD17B2 | |
| SCHEMBL12288637 | 0.87 | KDM4E (0.50) | L3MBTL1KDM4EATMALDH1A1MAPT | |
| SCHEMBL12362792 | 0.87 | L3MBTL1 (0.55) | L3MBTL1KDM4EATMHSD17B1HSD17B2 | |
| SCHEMBL20110428 | 0.87 | KDM4E (0.48) | L3MBTL1KDM4EATMHSD17B1HSD17B2 | |
| SCHEMBL29384509 | 0.85 | ATM (0.64) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL29432855 | 0.85 | ATM (0.64) | L3MBTL1KDM4EATMKMT2AIL1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210005827-A1 | N AND P ACTIVE MATERIALS FOR ORGANIC PHOTOELECTRIC CONVERSION LAYERS IN ORGANIC PHOTODIODES | SONY CORPORATION (JP) | 2021-01-07 | — | — | US | disclosed |
| US-10790454-B2 | N and P active materials for organic photoelectric conversion layers in organic photodiodes | SONY CORPORATION (JP) | 2020-09-29 | — | — | US | disclosed |
| US-20180123050-A1 | N AND P ACTIVE MATERIALS FOR ORGANIC PHOTOELECTRIC CONVERSION LAYERS IN ORGANIC PHOTODIODES | SONY CORPORATION (JP) | 2018-05-03 | — | — | US | disclosed |
| US-20180123050-A1 | N AND P ACTIVE MATERIALS FOR ORGANIC PHOTOELECTRIC CONVERSION LAYERS IN ORGANIC PHOTODIODES | SONY CORPORATION (JP) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10790454-B2 | N and P active materials for organic photoelectric conversion layers in organic photodiodes | L1CAM, PNN, JUP | L3MBTL1 2719/4885KDM4E 1801/4885ATM 847/4885 |
| US-20180123050-A1 | N AND P ACTIVE MATERIALS FOR ORGANIC PHOTOELECTRIC CONVERSION LAYERS IN ORGANIC PHOTODIODES | L1CAM, PNN, JUP | L3MBTL1 2719/4885KDM4E 1801/4885ATM 847/4885 |
| US-20210005827-A1 | N AND P ACTIVE MATERIALS FOR ORGANIC PHOTOELECTRIC CONVERSION LAYERS IN ORGANIC PHOTODIODES | L1CAM, PNN, JUP | L3MBTL1 2719/4885KDM4E 1801/4885ATM 847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.